This study demonstrated that laparoscopic surgery for early-stage ovarian cancer is associated with significant biochemical and clinical benefits, including reduced vascular endothelial growth factor (VEGF) and tumor marker levels, shorter recovery times, and improved 24-month survival rates. This evidence concerns the gene VEGFA and ovarian carcinoma.